Brimonidine Tartrate/Timolol Maleate

Actavis Pharma, Inc.🇺🇸 United States

FDA Page

Effective Date: Feb 28, 2022
Approval ID: 06fc923e-62ef-4fcd-838a-a880c4df4a89
Products: 1 registered
Version: 9

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION . BRIMONIDINE TARTRATE and TIMOLOL MALEATE solution, for topical administration Initial U.S. Approval: 2007

Quick Stats

Total Products1

Labelers2

Label Sections32

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.